HEALSEA Trademark

Trademark Overview

On Thursday, December 13, 2018, a trademark application was filed for HEALSEA with the United States Patent and Trademark Office. The USPTO has given the HEALSEA trademark a serial number of 79251117. The federal status of this trademark filing is REGISTERED as of Tuesday, September 10, 2019. This trademark is owned by Lallemand Pharma AG. The HEALSEA trademark is filed in the Pharmaceutical Products category with the following description:

Medicinal preparations for oral, nasal, and topical applications in the form of sprays for the prevention and treatment of pathogenic biofilm derived infections; medicinal preparations for the mouth and as sprays; decongestant nasal sprays
healsea

General Information

Serial Number79251117
Word MarkHEALSEA
Filing DateThursday, December 13, 2018
Status700 - REGISTERED
Status DateTuesday, September 10, 2019
Registration Number5854010
Registration DateTuesday, September 10, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 25, 2019

Trademark Statements

Goods and ServicesMedicinal preparations for oral, nasal, and topical applications in the form of sprays for the prevention and treatment of pathogenic biofilm derived infections; medicinal preparations for the mouth and as sprays; decongestant nasal sprays
Pseudo MarkHEAL SEA

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, February 11, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDanstar Ferment AG
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressCH
Party NameLallemand Pharma AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH
Party NameLallemand Pharma AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH
Party NameLallemand Pharma AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events

Event DateEvent Description
Tuesday, March 26, 2024CHANGE OF OWNER RECEIVED FROM IB
Friday, January 17, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, December 31, 2019FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, December 31, 2019FINAL DISPOSITION PROCESSED
Tuesday, December 10, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, September 10, 2019REGISTERED-PRINCIPAL REGISTER
Friday, June 28, 2019NOTIFICATION PROCESSED BY IB
Tuesday, June 25, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 25, 2019PUBLISHED FOR OPPOSITION
Wednesday, June 12, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, June 12, 2019NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, June 5, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, May 22, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 21, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 21, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, May 19, 2019ASSIGNED TO LIE
Monday, May 13, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 12, 2019REFUSAL PROCESSED BY IB
Wednesday, March 27, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 27, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, March 24, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, March 23, 2019REFUSAL PROCESSED BY MPU
Friday, March 22, 2019NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, March 19, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, March 18, 2019NON-FINAL ACTION WRITTEN
Monday, March 11, 2019ASSIGNED TO EXAMINER
Friday, February 15, 2019APPLICATION FILING RECEIPT MAILED
Monday, February 11, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 7, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

healsea sprays medicinal preparations nasal biofilm derived infections decongestant mouth pathogenic